Makers Laboratories Limited
Prices are adjusted according to historical splits.
Vitals
- Today's Low:
- ₹103.3
- Today's High:
- ₹106.35
- Open Price:
- ₹106
- 52W Low:
- ₹94
- 52W High:
- ₹166
- Prev. Close:
- ₹104.25
- Volume:
- 1517
Company Statistics
- Market Cap.:
- ₹504.97 million
- Book Value:
- 105.624
- Revenue TTM:
- ₹467.77 million
- Operating Margin TTM:
- 4.81%
- Gross Profit TTM:
- ₹214.77 million
- Profit Margin:
- 2.43%
- Return on Assets TTM:
- 1.82%
- Return on Equity TTM:
- 2.48%
Company Profile
Makers Laboratories Limited had its IPO on under the ticker symbol 506919.
The company operates in the Healthcare sector and Drug Manufacturers - Major industry. Makers Laboratories Limited has a staff strength of 135 employees.
Stock update
Shares of Makers Laboratories Limited opened at ₹106 at the start of the last trading session i.e. 2023-09-13.
The stocks traded within a range of ₹103.3 - ₹106.35, and closed at ₹104.35.
This is a +0.1% increase from the previous day's closing price.
A total volume of 1,517 shares were traded at the close of the day’s session.
In the last one week, shares of Makers Laboratories Limited have slipped by -3.38%.
Makers Laboratories Limited's Key Ratios
Makers Laboratories Limited has a market cap of ₹504.97 million, indicating a price to book ratio of 1.1638 and a price to sales ratio of 1.2884.
In the last 12-months Makers Laboratories Limited’s revenue was ₹467.77 million with a gross profit of ₹214.77 million and an EBITDA of ₹51.15 million. The EBITDA ratio measures Makers Laboratories Limited's overall financial performance and is widely used to measure its profitability.
In the trailing 12-month period, Makers Laboratories Limited’s operating margin was 4.81% while its return on assets stood at 1.82% with a return of equity of 2.48%.
In Q3, Makers Laboratories Limited’s quarterly earnings growth was a positive 200% while revenue growth was a negative 20.7%.
Makers Laboratories Limited’s PE and PEG Ratio
- Forward PE
- 0
- Trailing PE
- 53.0736
- PEG
Its diluted EPS in the last 12-months stands at ₹2.319 per share while it has a forward price to earnings multiple of 0 and a PEG multiple of . A low price to earnings ratio can mean the stock is attractively valued while a high ratio suggests the stock may be overvalued.
The PEG on the other hand provides a broader view compared to the P/E ratio and gives greater insight into Makers Laboratories Limited’s profitability.
Makers Laboratories Limited stock is trading at a EV to sales ratio of 1.4777 and a EV to EBITDA ratio of 13.273. Its price to sales ratio in the trailing 12-months stood at 1.2884.
Makers Laboratories Limited stock pays annual dividends of ₹1 per share, indicating a yield of 1.31% and a payout ratio of 0%.
Balance sheet and cash flow metrics
- Total Assets
- ₹1.52 billion
- Total Liabilities
- ₹275.38 million
- Operating Cash Flow
- ₹12.53 million
- Capital Expenditure
- ₹129.07 million
- Dividend Payout Ratio
- 0%
Makers Laboratories Limited ended 2025 with ₹1.52 billion in total assets and ₹0 in total liabilities. Its intangible assets were valued at ₹1.52 billion while shareholder equity stood at ₹692.01 million.
Makers Laboratories Limited ended 2025 with ₹0 in deferred long-term liabilities, ₹275.38 million in other current liabilities, 59004000.00 in common stock, ₹633.01 million in retained earnings and ₹0 in goodwill. Its cash balance stood at ₹0 and cash and short-term investments were ₹49.79 million. The company’s total short-term debt was ₹45,542,000 while long-term debt stood at ₹43.18 million.
Makers Laboratories Limited’s total current assets stands at ₹633.37 million while long-term investments were ₹0 and short-term investments were ₹6.10 million. Its net receivables were ₹198.67 million compared to accounts payable of ₹0 and inventory worth ₹313.21 million.
In 2025, Makers Laboratories Limited's operating cash flow was ₹12.53 million while its capital expenditure stood at ₹129.07 million.
Comparatively, Makers Laboratories Limited paid ₹0 in dividends in 2025.
Other key metrics
- Current Trading Price
- ₹104.35
- 52-Week High
- ₹166
- 52-Week Low
- ₹94
- Analyst Target Price
- ₹
Makers Laboratories Limited stock is currently trading at ₹104.35 per share. It touched a 52-week high of ₹166 and a 52-week low of ₹166. Analysts tracking the stock have a 12-month average target price of ₹.
Its 50-day moving average was ₹112.74 and 200-day moving average was ₹112.05 The short ratio stood at 0 indicating a short percent outstanding of 0%.
Around 6644.2% of the company’s stock are held by insiders while 0% are held by institutions.
Frequently Asked Questions About Makers Laboratories Limited
Similar Industry Stocks (Drug Manufacturers - Major)
Most Active
Top Gainers
Top Losers
About
Makers Laboratories Limited, an integrated pharmaceutical company, manufactures and markets formulations in India. The company offers products in general health therapeutic segments, including acid regulatory, anthelmintic, anti-allergic, anti-asthmatic, anti-biotic, anti-diabetics, anti-diarrhoeal, anti-emetics and anti-nauseants, anti-fungal, anti?inflammatory, analgesic, anti-spasmodic, anti-malarial, anti-thyroid, cough and cold control, digestives, neurotonic, nutritional supplements, topical anti-biotic/anti-microbial, and other specialties. It also provides diabetic and hypertensive drugs. The company’s principal formulation brands comprise Duramol, Artemak-AB, Loroquin, Nimuwin, Coffwin, and Exylin. It serves approximately 1,500 stockiests’; 1,00,000 doctors; and 2,00,000 retailers through a distribution network of 20 consignment agents and 15 super stockiests’. The company was incorporated in 1984 and is based in Mumbai, India.